Hospital for Special Surgery - Archive (Scleroderma and Vasculitis Center)

2019
June
10,
2019
| 11:00 PM America/New_York
CreakyJoints.org featuring Lindsay S. Lally, MD ...
Read more
March
20,
2019
| 01:00 PM America/New_York
Hospital for Special Surgery is evaluating a novel therapeutic approach for diffuse cutaneous systemic sclerosis (dcSSc), one of the most serious, potentially disabling and life-threatening rheumatic diseases. The double-blind, randomized, placebo-co...
Read more
2018
November
19,
2018
| 01:00 PM America/New_York
Robert F. Spiera, MD, rheumatologist at HSS, is interviewed at the annual ACR conference by MedPage Today talking about the study that he presented on the safety and efficacy of lenabasum in diffuse scleroderma patients. He explains how his team saw...
Read more
January
10,
2018
| 01:00 PM America/New_York
Scleroderma is a terribly debilitating disease with no effective treatments and the mortality rates are still upwards of 20%-50%, the highest of any rheumatic disease. This disabling autoimmune disorder results in inflammation and fibrosis leading t...
Read more